Category: Life Sciences
Global Life Sciences
-
Angioplasty Balloons
... CAGR of 3.9% over the analysis period 2024-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More
-
Antioxidants
... 5.7% over the analysis period 2024-2030. Synthetic Antioxidants, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More
-
Artificial Pancreas Device Systems
... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More
-
Aseptic Processing
... CAGR of 3.5% over the analysis period 2024-2030. Vials & Ampoules Packaging, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$51.3 Billion by the end of ... Read More
-
Automotive Camshaft
... CAGR of 4.4% over the analysis period 2024-2030. Forged Camshaft, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More
-
Bioactive Materials
... CAGR of 9.0% over the analysis period 2024-2030. Glass Material, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$3.2 Billion by the end of the analysis ... Read More
-
Bioprocess Containers
... CAGR of 23.7% over the analysis period 2024-2030. 2D Bioprocess Containers, one of the segments analyzed in the report, is expected to record a 27.1% CAGR and reach US$22.3 Billion by the end of the ... Read More
-
Blood Pressure Transducers
... at a CAGR of 5.7% over the analysis period 2024-2030. Disposable Transducers, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$512.1 Million by the end of ... Read More
-
Botanical Supplements
... CAGR of 8.0% over the analysis period 2024-2030. Spices, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$22.3 Billion by the end of the analysis period. ... Read More
-
Bread Improvers
... CAGR of 4.6% over the analysis period 2024-2030. Powder Form, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Burn Care
... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Cable Modem Termination System (CMTS) and Converged Cable Access Platform (CCAP)
... at US$7.1 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. CCAP, one of the segments analyzed in the report, ... Read More
-
Cardiac Resynchronization Therapy (CRT) Devices
... Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. CRT-Defibrillator (CRT-D), one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion ... Read More
-
Cell Culture Protein Surface Coating
... Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Animal-Derived Protein Source, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.5 ... Read More
-
Ceramic Textiles
... CAGR of 8.3% over the analysis period 2024-2030. RCF Fiber, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$160.7 Million by the end of the analysis ... Read More
-
Cervical Pillows
... CAGR of 5.4% over the analysis period 2024-2030. Standard Pillows, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Clinical Data Analytics
... at a CAGR of 34.4% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$32.6 Billion by the end of ... Read More
-
Clot Management Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Cold Pressed Juices
... at a CAGR of 5.6% over the analysis period 2024-2030. Organic Cold Pressed Juices, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Complex-Oxide Nanomaterials
... CAGR of 11.9% over the analysis period 2024-2030. Lithium Titanate, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
-
Computational Biology
... CAGR of 18.1% over the analysis period 2024-2030. Contract Services, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$20.1 Billion by the end of the analysis ... Read More
-
GMO Testing
... CAGR of 7.0% over the analysis period 2024-2030. Stacked Trait Testing, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Hernia Repair Devices
... at a CAGR of 4.9% over the analysis period 2024-2030. Hernia Mesh, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.8 Billion by the end of ... Read More
-
Healthcare Payer Services
... at a CAGR of 6.1% over the analysis period 2024-2030. ITO Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$50.4 Billion by the end of ... Read More
-
Heart Pump Devices
... at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the ... Read More
Research Assistance
